NIH study finds experimental drug benefits patients with rare type of cancer, June 6, 2011, News Release - National Institutes of Health (NIH)
Links shared publicly online about this topic.
- 238total visits
NIH study finds experimental drug benefits patients with rare type of cancer, June 6, 2011, News Release - National Institutes of Health (NIH)
nih.gov —
An experimental drug, cediranib, may benefit patients with a rare, slow-growing cancer called alveolar soft part sarcoma (ASPS), according to results from a clinical trial. The trial, carried out by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health, showed that tumors shrank in more than 50 percent of ASPS patients who were treated with cediranib. These findings were presented at the American Society of Clinical Oncology annual meeting in Chicago on Jun
View full resource at nih.gov
Tags: Cancer, Drug, Clinical Trial, Healthy Living, National Institutes of Health, Scientist, News
Most Recently Shared on June 6, 2011 at 7:22 pm By:
News: NIH study finds experimental drug benefits patients with rare type of cancer known as ASPS http://1.usa.gov/jkpD0M - #health
Advertisement
